Quarterly report pursuant to Section 13 or 15(d)

Temporary Equity and Stockholders' Deficiency (Details Narrative)

v3.20.2
Temporary Equity and Stockholders' Deficiency (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Jan. 31, 2019
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Foreign currency translation adjustments   $ 128,051 $ 8,339  
Options [Member]        
Number of stock options granted during the period      
Share based compensation   $ 103,581 157,994  
Employee service share-based compensation, nonvested awards, compensation not yet recognized, stock options   $ 964,345    
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition   2 years 6 months    
2018 Equity Incentive Plan [Member]        
Stock option term P5Y      
Number of stock options granted during the period 1,350,000      
Option exercise price per share $ 0.385      
Percentage of option vested 25.00%      
Stock option vesting term 3 years      
Stock option grant date fair value $ 200,092    
2018 GGI Options [Member]        
Number of stock options granted during the period       6,595,000
Weighted average grant date value       $ 0.14
Common Stock [Member] | 2018 Equity Incentive Plan [Member]        
Number of stock options granted during the period 1,100,000      
Common Stock [Member] | 2018 Equity Incentive Plan [Member] | Certain Members of Board of Directors [Member]        
Number of stock options granted during the period 100,000      
Common Stock [Member] | 2018 Equity Incentive Plan [Member] | Consultants [Member]        
Number of stock options granted during the period 150,000      
Series B Preferred Stock [Member]        
Cumulative cash dividends annual rate   8.00%    
Shares issued, price per share   $ 10    
Deemed dividends earned   $ 179,770 177,795  
Dividends payable   85,223    
Preferred stock, amount of cumulative dividends dividends in arrears   $ 1,444,131 $ 1,264,361